Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature.
11/20/19 • 31 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/sccm-podcast-421/sccm-pod-400-are-aki-biomarkers-ready-for-clinical-use-18289849"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to sccm pod-400 are aki biomarkers ready for clinical use? on goodpods" style="width: 225px" /> </a>
Copy